The National Organization for Rare Disorders (NORD)


Database Subscriptions

Many libraries, schools, universities, and hospitals subscribe to NORD’s Rare Disease Database for unlimited access to reports on more than 1,150 diseases.

Index of Rare Diseases

This is the list of diseases currently covered in the Rare Disease Database.

Rare Disease Database

Search this database for reports on more than 1,150 diseases.

View sample report

Index of Organizations

This is the list of organizations in NORD’s Organizational Database.

Organizational Database

Read about more than 2,000 patient organizations and other sources of help.

NORD's
Washington Office

Check here to read about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.

 

News Briefs

ICORD 2008

Global Approaches for Rare Diseases Research and Orphan Products Development

May 20-22, 2008
Washington DC, USA

The 4th International Conference on Rare Diseases and Orphan Drugs (ICORD) will take place in Washington, DC, on May 20-22, 2008. All individuals active in rare diseases and/or orphan products are invited.

Co-organizers of the program are Stephen Groft, PharmD, Director of the Office of Rare Diseases at the National Institutes of Health, and Jan-Inge Henter, MD, PhD, Professor of Pediatrics, Karolinska Institutet, Stockholm, Sweden.

The meeting will be held in conjunction with NORD’s 2008 Tribute Banquet and with a meeting of the NORD Corporate Council.

The overall aim of the ICORD 2008 meeting will be to develop constructive international collaborations from which patients will benefit. The ICORD mission is to improve the welfare of people affected by rare diseases through enhanced knowledge, research, care, information, education and awareness.

More information on this meeting is provided on the website of ICORD: www.icord.se. The themes for ICORD 2008 will be:

  • Facilitating the Harmonization of the Regulatory Processes
  • Linking Academic Discoveries and Industry
  • Product Development Resources
  • Rare Diseases Research Assessment Tools
  • Clinical Trials of Rare Diseases and Orphan Products
  • Genetic Testing
  • Meeting Patient and Family Needs Across the Lifespan--Model Programs
  • Expanding the Information and Research Borders for Rare Diseases
A warm welcome to ICORD 2008!
Stephen Groft, Pharm.D.
Director
Office of Rare Diseases, NIH
Bethesda, MD, USA
Jan-Inge Henter, M.D., Ph.D.
Professor of Pediatrics
Karolinska Institutet
Stockholm, Sweden
Contacts
Practical Issues Programme issues
Kimberly Potter
kimberly.c.potter@lmco.com
Maria Wastfelt
maria.wastfelt@ki.se

Désirée Gavhed
desiree.gavhed@ki.se

Enter your e-mail address if you would like to receive "News Blasts" from NORD

ABOUT | CONTACT NORD

Since 1983, working toward the prevention, treatment, and cure of rare “orphan” diseases.

Previous News Briefs

ICORD 2008

FDA and European Union Adopt Shared Form

NORD Representatives Address Congress

CETT Increases Access to Genetic Tests

NORD Honors Innovators at 2007 Tribute Banquet

FDA Approves First Product for PNH

NORD Staff and Rare-Disease Researchers Describe Their Work for Wife of President of Germany

A Common Lesson of Rare Diseases

NORD Issues RFPs

Deadline Announced for Grant Applications

Conference in Korea Focuses on Rare Diseases

FDA Approves Revlimid For Multiple Myeloma

Penn Researchers Pinpoint Cause of FOP

FDA Approves HDE for Rare Disorder of Placenta

CFC Genes Identified With Help of Patient Organization

Saving Andy Martin’s Cells

Haffner Honored by Royal College of Physicians

NORD President Honored For Health Advocacy

NIH Opens New Clinical Research Hospital

Gulf War ALS Study Results Reported

Researchers Identify Progeria Gene

Dystonia Patients Gain Access to "Brain Pacemaker"

Scientists Block CJD-Like Illness in Mice

Genetic Signature Linked to Severe Lupus Symptoms

Genes Linked to Methylmalonic Aciduria Identified

French Researchers Claim a Cure for Severe Sickle Cell

NF1 Research: When a Good Gene Goes Bad

Thalidomide Shows Promise

For Smallpox: Vaccine Production on Target

NORD Member Organization Update August 2002

FDA Approves New "Orphan Drug"

Supreme Court Narrows Disability Law

Dramatic Results Reported in Stiff Person Syndrome Study

Gulf War Vets Have Higher Rate of ALS

Diseases of Bioterrorism

Stay connected!

If you liked these News Briefs, you’ll love our free e-mail News Blasts. You’ll receive breaking news affecting the rare-disease community directly in your inbox if you enter your e-mail address in the box at the top of this page.

ABOUT NORD .|. CONTACT NORD .|. MEMBERSHIP .|. NORD MARKETPLACE .|. PRIVACY POLICY .|. DISCLAIMER .|. HOME
©2006 NORD - National Organization for Rare Disorders, Inc. All rights reserved.

Last modified Monday, June 02, 2008